Commentary Contraception

Leadership in Pharmaceutical Companies: Where Are the Women?

Lauren Martin

As I read Jezebel’s piece on evil birth control manufacturers, I found myself wondering who exactly is running these malicious pharmaceutical companies? Is it, as I see it in my head, a bunch of old pasty men—not a vagina in sight?

As I read Jezebel’s piece on evil birth control manufacturers, I found myself wondering who exactly is running these malicious pharmaceutical companies? Is it, as I see it in my head, a bunch of old pasty men—not a vagina in sight?

I had a feeling I knew the answer, but figured I’d find out for sure.

Bayer

Feast your eyes on the sausage fest that is Bayer’s Executive Committee: 12 out of the 13 members are men.

Appreciate our work?

Rewire is a non-profit independent media publication. Your tax-deductible contribution helps support our research, reporting, and analysis.

DONATE NOW

Pfizer

Good ol’ Pfizer does a little better—having a whole three women on their 13-member Executive Leadership Team. (Don’t worry, though. Their board also has a whopping three women.)

Johnson & Johnson

Keeping with the rule of threes, Johnson & Johnson’s board is 33.33% women.

Merck

Another trio of ladies sits on Merck’s board—but they account only for 5.6% of this 17-member team. (Their Executive Committee doesn’t make up for it.)

Warner Chilcott

Jezebel couldn’t find too much evidence of evil here. And there are no women to be found on their board. (Got the magic three on their Leadership Team, though.)

So what does this mean? Maybe nothing. Maybe pharmaceutical companies will inevitably be evil no matter what gender leads them. Maybe the lack of ovaries on their board of directors does make them more likely to fail at women’s health.

I know not. But c’mon, folks…it certainly couldn’t hurt to get a few more women leading your companies.

Topics and Tags:

Access to contraception

Load More

We must defend reproductive rights at every level. That includes staying informed. Sign up for our email list now.

Thank you for reading Rewire!